The Ebola vaccine that has already been used in an ongoing outbreak in Congo against the often deadly disease, is the first approved by the U.S. Food and Drug Administration.
The vaccine, known as Ervebo and developed by the pharmaceutical company Merck, was tested in West Africa during the 2014–2016 Ebola outbreak and was found to be effective in preventing infection.
The vaccine was approved for those 18 years of age and older to prevent disease caused by one Ebola virus species, Zaire ebolavirus. The decision of the FDA, announced on December 19, follows in the footsteps of the November approval of European regulators.
According to the World Health Organization (SN: 5/21/18), there had been 3,351 cases and 2,211 deaths in the spread of Ebola in Congo as of December 18. About 250,000 people were vaccinated.
The vaccine has helped health officials working to control the outbreak as well as new treatments for those already infected.
In a clinical trial performed during the epidemic, two of the four therapies were found to be effective in preventing death from the disease.
The number of new cases has declined, but there are still treacherous conditions in the country for those working to bring the outbreak to an end.
At the end of November, four workers aided in the outbreak including a vaccine team member, were killed by armed attackers.


Choose A Format
Personality quiz
Series of questions that intends to reveal something about the personality
Trivia quiz
Series of questions with right and wrong answers that intends to check knowledge
Voting to make decisions or determine opinions
Formatted Text with Embeds and Visuals
The Classic Internet Listicles
The Classic Internet Countdowns
Open List
Submit your own item and vote up for the best submission
Ranked List
Upvote or downvote to decide the best list item
Upload your own images to make custom memes
Youtube, Vimeo or Vine Embeds
Soundcloud or Mixcloud Embeds
Photo or GIF
GIF format